Salud financiera de hoja de balance de Evolent Health
Salud financiera controles de criterios 4/6
Evolent Health tiene un patrimonio de accionistas total de $1.2B y una deuda total de $597.0M, lo que sitúa su ratio deuda-patrimonio en 47.9%. Sus activos y pasivos totales son $2.7B y $1.4B respectivamente. El BAIT de Evolent Health es de $30.8M, por lo que su ratio de cobertura de intereses es de 0.6. Tiene efectivo e inversiones a corto plazo que ascienden a $192.8M.
Información clave
47.9%
Ratio deuda-patrimonio
US$597.05m
Deuda
| Ratio de cobertura de intereses | 0.6x |
| Efectivo | US$192.83m |
| Patrimonio | US$1.25b |
| Total pasivo | US$1.43b |
| Activos totales | US$2.68b |
Actualizaciones recientes sobre salud financiera
Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt
Jan 17
Does Evolent Health (NYSE:EVH) Have A Healthy Balance Sheet?
Sep 29Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt
May 30Is Evolent Health (NYSE:EVH) A Risky Investment?
Feb 19Is Evolent Health (NYSE:EVH) A Risky Investment?
Aug 05Recent updates
Evolent Health, Inc. (NYSE:EVH) Doing What It Can To Lift Shares
Apr 08Evolent Health (NYSE:EVH) Is Experiencing Growth In Returns On Capital
Mar 12Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt
Jan 17Many Still Looking Away From Evolent Health, Inc. (NYSE:EVH)
Dec 21Evolent Health (NYSE:EVH) Is Looking To Continue Growing Its Returns On Capital
Nov 30A First Evaluation On Evolent Health
Oct 04Does Evolent Health (NYSE:EVH) Have A Healthy Balance Sheet?
Sep 29There's Been No Shortage Of Growth Recently For Evolent Health's (NYSE:EVH) Returns On Capital
Sep 01An Intrinsic Calculation For Evolent Health, Inc. (NYSE:EVH) Suggests It's 47% Undervalued
Aug 04Evolent Health: Business Economics Still Appealing, Reiterate Buy
Jul 19Cautious Investors Not Rewarding Evolent Health, Inc.'s (NYSE:EVH) Performance Completely
Jun 14Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt
May 30An Intrinsic Calculation For Evolent Health, Inc. (NYSE:EVH) Suggests It's 34% Undervalued
May 02Evolent Health (NYSE:EVH) Shareholders Will Want The ROCE Trajectory To Continue
Apr 17Evolent Health GAAP EPS of $0.11 beats by $0.13, revenue of $382.4M beats by $9.47M
Feb 22Is Evolent Health (NYSE:EVH) A Risky Investment?
Feb 19Evolent Health: Strengthening Fundamentals, Investing At High Rates Of Return
Feb 15Is Evolent Health, Inc. (NYSE:EVH) Potentially Undervalued?
Feb 01Evolent Health (NYSE:EVH) Might Have The Makings Of A Multi-Bagger
Jan 14Evolent spikes as Humana partnership expands
Jan 12Is Evolent Health, Inc. (NYSE:EVH) Trading At A 49% Discount?
Dec 27Evolent Health offered $23.5M class action securities settlement
Sep 19Evolent Health's (NYSE:EVH) Returns On Capital Are Heading Higher
Sep 18Evolent Health: Improving Financials, But There's More
Aug 31Is Evolent Health (NYSE:EVH) A Risky Investment?
Aug 05Evolent Health initiated at outperform at RBC on organic revenue growth opportunity
Jul 29Evolent Health: Strong Growth, Priced At 2x Sales, What To Know
Jul 11Evolent Health: Healthy Growth, But That Is About It
Jun 30Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo ($683.7M) de EVH superan a sus pasivos a corto plazo ($674.2M).
Pasivo a largo plazo: Los activos a corto plazo ($683.7M) de EVH no cubren sus pasivos a largo plazo ($759.9M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: El ratio deuda neta-patrimonio (32.4%) de EVH se considera satisfactorio.
Reducción de la deuda: El ratio deuda-patrimonio de EVH ha crecido de 18.6% a 47.9% en los últimos 5 años.
Hoja de balance
Análisis de cash runway
En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.
Cash runway estable: Aunque no es rentable EVH tiene suficiente cash runway para más de 3 años si mantiene su actual nivel positivo de flujo de caja libre.
Pronóstico de cash runway: EVH no es rentable pero tiene suficiente cash runway para más de 3 años, debido a que el flujo de caja libre es positivo y crece un 33.1% al año.